The Latest Breaking News from FDA

The jobs report looms with Treasury yields soaring. Meta is among stocks holding up as Threads had record first-day downloads.

Eisai and Biogen's Leqembi is the first drug to slow Alzheimer's progression to receive full FDA approval.

Biogen stock skidded Friday after the Food and Drug Administration fully approved its Alzheimer's treatment, Leqembi.

With the growing prevalence of chronic conditions, an aging population, widespread adoption of digital technologies, and several R&D efforts, the pharmaceutical industry is poised for exponential growth and expansion. So, let’s compare leading pharma stocks AbbVie (ABBV) and Pfizer (PFE) to identify which is a better investment now. Keep reading….

FDA approves new test, which has been widely celebrated as a small victory in the fight to make childbirth safer in the US

Vaccines to stave off the flu, a new COVID variant and now, respiratory syncytial virus could help avert another tripledemic this fall. Unless the public is too crisis-fatigued to care.

The idea seems simple enough.

"While reports like these can understandably be worrying, there's no reason to panic at this stage"

Over the past twenty years, Lyme disease cases have continued to climb, and we are finally tantalizingly close to another vaccine.